# China NMPA Drug Inspection - Sinopharm Group Weichida Pharmaceutical Co., Ltd. - Amoxicillin capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/sinopharm-group-weichida-pharmaceutical-co-ltd/ceffdb7c-549f-4ebd-aaa1-983f00e04a55/
Source feed: China

> China NMPA drug inspection for Sinopharm Group Weichida Pharmaceutical Co., Ltd. published November 16, 2021. Drug: Amoxicillin capsules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 3, 2021)
- Company Name: Sinopharm Group Weichida Pharmaceutical Co., Ltd.
- Publication Date: 2021-11-16
- Drug Name: Amoxicillin capsules
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/sinopharm-group-weichida-pharmaceutical-co-ltd/6d30d149-8930-4496-a20e-c82d8224efcc/